Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
CVOTs have shown that GLP-1 receptor agonists reduce MACE in patients with T2D compared to placebo
Several placebo-controlled clinical trials have confirmed the observed effects [37]
At a Glance Medications Offered Compounded Semaglutide, Compounded Tirzepatide, Ozempic, Zepbound Both Cost & Insurance Monthly: $117-$359/mo 6-month estimate: $702-$2,154 Insurance: Yes Self-pay: Yes Clinical Features Lab testing: No Dietitian access: Yes Verified Pharmacy: Network of 503A-accredited pharmacies
Storage Keep in a cool, dry, dark place
ICER can suggest a value-based price benchmark (i.e
US$ 28.61
US$ 23.69
US$ 22.90
US$ 29.80
US$ 28.78
US$ 22.65
